✦ LIBER ✦

Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: A review

✍ Scribed by Giorgos Papaspyrou; Stephan Hoch; Alessandra Rinaldo; Juan P. Rodrigo; Robert P. Takes; Carla van Herpen; Jochen A. Werner; Alfio Ferlito

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 111 KB
Volume: 33
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.21458

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Adenoid cystic carcinoma (ACC) is an uncommon tumor usually arising in the head and neck region, mainly in the salivary glands. It demonstrates an indolent prolonged course and is characterized by perineural invasion. Primary treatment of local and locoregional disease consists mainly of surgery and/or irradiation. During follow‐up these patients frequently develop local recurrences and distant metastases, especially in the lung, although long‐term survival is possible. The role of chemotherapy in ACC is limited, and studies with only a limited number of patients are performed. In this article we review the literature on chemotherapy regimens, including monotherapy and combination chemotherapy schedules, as well as the new targeted therapies. © 2010 Wiley Periodicals, Inc. Head Neck, 2011

📜 SIMILAR VOLUMES

Cisplatin-based chemotherapy in advanced

Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck

✍ L. De Dick Haan; Dr. Pieter H. M. De Mulder; Dr. Jan B. Vermorken; Dr. Jan H. Sc 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB 👁 2 views

Nineteen patients, nine men and 10 women, with advanced adenoid cystic carcinoma (ACC), were treated with cisplatin either alone or in combination with doxorubicin and bleomycin. Median age was 51 years (range: 32-73 years). Two groups of patients were distinguished: Group 1 (N = 10) received single

5-Fluorouracil, Cyclophosphamide, and Vi

5-Fluorouracil, Cyclophosphamide, and Vincristine for Adenoid Cystic Carcinoma of the Head and Neck

✍ Pierre L. Triozzi; Alton Brantley; Samuel Fisher; T. Boyce Cole; Ian Crocker; An 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

Targeted therapies in squamous cell carc

Targeted therapies in squamous cell carcinoma of the head and neck

✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r

Radiotherapy alone or combined with surg

Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck

✍ William M. Mendenhall; Christopher G. Morris; Robert J. Amdur; John W. Werning; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

## Abstract ## Purpose. The purpose of this study was to analyze the results of radiotherapy (RT) alone or combined with surgery for adenoid cystic carcinoma. ## Methods. Between September 1966 and November 2001, 101 previously untreated patients were treated with curative intent with RT alone o

Aberrant cytokine expression in serum of

Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck

✍ Thomas K. Hoffmann; Eniko Sonkoly; Bernhard Homey; Katrin Scheckenbach; Christia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Background. Squamous cell carcinoma (SCC) and adenoid cystic carcinoma (ACC) represent 2 clinically important subtypes of head and neck cancer. Our objective was to characterize and compare cytokine profiles in the systemic circulation of patients with SCC and ACC. ## Methods. Mul

Targeted therapy in head and neck cancer

Targeted therapy in head and neck cancer : State of the art 2007 and review of clinical applications

✍ Corey J. Langer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

## Abstract In patients with squamous cell carcinoma of the head and neck (SCCHN), tumor recurrence, secondary tumors, and comorbidities contribute to therapy failure, and treatment approaches often are limited by their toxicity. With the incorporation of targeted therapies, the number of options a